Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MGN:GR

4.880 EUR 0.0000.00%

As of 11:36:29 ET on 05/29/2015.

Snapshot for Mologen AG (MGN)

Open: 4.920 Day's Range: 4.860 - 5.000 Volume: 9,880
Previous Close: 4.880 52wk Range: 4.400 - 11.105 1-Yr Rtn: -54.56%

Stock Chart for MGN

No chart data available.
  • MGN:GR 4.970
  • 1D
  • 1M
  • 1Y
4.880
Interactive MGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.9472
Est. EPS (EUR) (12/2015) -1.0030
Est. PEG Ratio -
Market Cap (M EUR) 110.44
Shares Outstanding (M) 22.63
30 Day Average Volume 31,780
Price/Book (mrq) 8.7364
Price/Sale (ttm) 3,649.4778
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MGN

Mologen AG researches, develops and markets products in the area of biotechnology and molecular medicine. The Company develops delivery technologies for DNA-based vaccines (gene therapy). In addition, Mologen writes software applications that are used in the laboratory by medical researchers.

Matthias SchroffChairman-Mgmt Board/CEOJoerg PetrassCFO/Member-Mgmt Board
Alfredo ZurloChief Medical Officer
More Company Profile & Key Executives for MGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil